Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2246]
News [4606]
Articles [190]
Editorials [8]
Conferences [133]
elearning [9]
Society and money - the cancer conundrum
Prof Richard Sullivan – Kings College, London, UK
Society and money - the cancer conundrum ( Prof Richard Sullivan – Kings College, London, UK )
17 Jul 2012
Translating cancer research to personalised treatment: Can it work?
Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Translating cancer research to personalised treatment: Can it work? ( Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
17 Jul 2012
Highlights of the 22nd EACR meeting and tackling glioblastoma
Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012
Adjuvant cetuximab disappoints again in mCRC
Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012
The WINTHER study
Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA
The WINTHER study ( Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA )
16 Jul 2012
Use of electronic data to raise the standard of cancer care
Brett Davis – Oracle Corporation, USA
Use of electronic data to raise the standard of cancer care ( Brett Davis – Oracle Corporation, USA )
16 Jul 2012
Drugging the cancer genome: opportunities and challenges
Prof Paul Workman - Institute of Cancer Research, UK
Drugging the cancer genome: opportunities and challenges ( Prof Paul Workman - Institute of Cancer Research, UK )
16 Jul 2012
A new direction for development of targeted cancer therapies
Dr Edison Liu – Jackson Laboratory, USA
A new direction for development of targeted cancer therapies ( Dr Edison Liu – Jackson Laboratory, USA )
16 Jul 2012
Vandetanib increases progression free survival in medullary thyroid carcinoma
Dr Nick Botwood - AstraZeneca, UK
Vandetanib increases progression free survival in medullary thyroid carcinoma ( Dr Nick Botwood - AstraZeneca, UK )
13 Jul 2012
WINTHER: The WIN therapeutics clinical trial
Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...
WINTHER: The WIN therapeutics clinical trial ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
13 Jul 2012
Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012
Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter...
Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands, )
13 Jul 2012
Use of genetic variance to identify potential therapeutic targets
Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA
Use of genetic variance to identify potential therapeutic targets ( Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA )
11 Jul 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation